Reported Feb 13, 2013 · Terminated
Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 Capsules per bottle, Rx only,…
Watson Pharmaceuticals
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Watson Pharmaceuticals · 400 Interpace Pkwy · Parsippany, NJ · 07054-1120
Is this the product you have?
- Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 Capsules per bottle, Rx only
- Manufactured byWatson Laboratories, Inc., Corona, CA 92880
- Distributed byWatson Pharma, NDC 62037-700-90
- Lot codes and dates
Lot #: 512146AExp 01/31/2014
- Amount recalled
- 3,040 bottles
Where it was sold
- Nationwide
- PR
Why it was recalled
Failed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41% (specification: 20-40%).
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Watson Pharmaceuticals recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.